Non-invasive liver profile testing

Developed by scientists at the VIB University of Ghent, Belgium, the Glyco Liver Profile test from Helena Biosciences is the first of its kind delivering a comprehensive picture of chronic liver disease enabling clinicians to diagnose and monitor patients with hepatic inflammation, fibrosis and cirrhosis while providing a prognostic marker of hepatocellular carcinoma (HCC) risk.

The test is conducted utilising capillary electrophoresis on Helena Biosciences’ V8 NEXUS analyser, with patient results displayed on Platinum 5 Touchscreen software. Dr Adam Stephenson, Director of Sales and Marketing at Helena Biosciences, said: “This is a huge year for the Glyco Liver Profile test and for Helena Biosciences. We have a brand new multi-analyte liver marker that has the potential to be a reference test in hospitals around the world.

“This is a truly innovative test utilising glycomic biomarkers to diagnose and predict the stage and prognosis of liver damage, regardless of the aetiology. Given that we have a global installation base known for myeloma and thalassemia testing, this is one more powerful biomarker that we can roll out to the fleet.”

www.helena-biosciences.com/GLP

 

Other news

Upcoming Events

Update Course in Gynaecological Cytology

London Regional Cytology Training Centre, Level 6X, St Marks Building, Watford Road, Harrow HA1 3UJ
12-14 December 2018

Managing Cultural Differences in the Workplace

The Holiday Inn - Kensington Forum, 97 Cromwell Road, London SW7 4DN
21 January 2019

British Society for Haematology Paediatric Symposium

Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London WC1X 8SH
14 February 2019

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Dec 2018

Molecular diagnostics and LAMP technology

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.